Published in Hepatitis Weekly, August 9th, 1999
Researcher S. Kamei and colleagues from Tokyo's Nihon University School of Medicine estimated the effect of brain function due to interferon (IFN)-alpha in chronic hepatitis C patients by the quantitative EEG ("Blinded, Prospective, and Serial Evaluation by Quantitative-EEG in Interferon-Alpha-Treated Hepatitis C," Acta Neurol Scand, July 1999;100(1):25-33).
Fifty-six chronic hepatitis C patients were administered IFN-alpha intramuscularly at 9x106 IU daily for the first four weeks and then three...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.